Evidence map›Paper›PMID 39263051›Full record

ArticleHeliyon2024

Seroprevalence of SARS-CoV-2 nucleocapsid antibody among sex workers during the 5th epidemic wave with Omicron variant in Chiang Mai, Thailand.

Sayamon Hongjaisee, Ratchadakorn Guntala, Arunrat Tangmunkongvorakul, Nicole Ngo-Giang-Huong, Woottichai Khamduang

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sayamon HongjaiseeResearch Institute for Health Sciences, Chiang Mai University, Chiangmai, Thailand.
Ratchadakorn GuntalaResearch Institute for Health Sciences, Chiang Mai University, Chiangmai, Thailand.
Arunrat TangmunkongvorakulResearch Institute for Health Sciences, Chiang Mai University, Chiangmai, Thailand.
Nicole Ngo-Giang-HuongMaladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle (MIVEGEC), Agropolis University Montpellier, Centre National de la Recherche Scientifique (CNRS), Institut de Recherche Pour le Développement (IRD), Montpellier, France.
Woottichai KhamduangLUCENT international collaboration, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the seroprevalence of SARS-CoV-2 nucleocapsid antibodies (NC-Ab) in sex workers. Methods: A cross-sectional/observational study was conducted between March and December 2022 among sex workers living in Chiangmai, Thailand, aged over 18 years and who had engaged in sex work in the previous 12 months. Consenting individuals completed a questionnaire and had blood drawn. IgG-specific for SARS-CoV-2 nucleocapsid was assessed using Euroimmun anti-SARS-CoV-2 NCP ELISA (IgG). Results: 264 sex workers (52.3 % male) with a median age 31 years were included. The overall seroprevalence of SARS-CoV-2 NC-Ab was 42.4 % (44.2 % in males, 40.5 % in females). It was significantly higher among non-Thai than Thai sex workers (57.1 % vs. 37.1 %, Conclusions: This study shows a high seroprevalence of NC-Ab among sex workers in Chiangmai, Thailand during the fifth epidemic wave with Omicron variant. This may be due to combined effects of high transmissibility of the Omicron variant and high-risk behavior of those individuals. Specific health education interventions are needed for this specific population.

Indexed as

Anti-nucleocapsidCOVID-19SARS-CoV-2 antibodiesSeroprevalenceSex workersThailand

Identifiers

PMID39263051
PMCPMC11388775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.